Journals

touchENDOCRINOLOGY publishes two peer-reviewed, free-to-access journals, that aim to provide insightful and topical articles relevant to the day-to-day practice of busy physicians. View our latest and archive content below.

More information about our journals along with how to submit your work can be found here.

Journals Content

COVID-19, Diabetes

Challenges in Women with Diabetes During the COVID-19 Pandemic

Gagan Priya, Sarita Bajaj, Emmy Grewal, Indira Maisnam, Sruti Chandrasekharan, Chitra Selvan

European Endocrinology. 2020;16(2):Online ahead of journal publication

The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly to become a global health threat. The disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel β-coronavirus that belongs to a family of enveloped RNA viruses, the coronaviruses.1 While some of the coronaviruses cause common flu, other strains, such as SARS-CoV, Middle East respiratory syndrome […]

Diabetes

Prevalence of Primary Non-adherence with Insulin and Barriers to Insulin Initiation in Patients with Type 2 Diabetes Mellitus – An Exploratory Study in a Tertiary Care Teaching Public Hospital

Suresh K Sharma, Ravi Kant, Sanjay Kalra, Ravin Bishnoi

European Endocrinology. 2020;16(2):Online ahead of journal publication

The management of type 2 diabetes mellitus (T2DM) involves multifactorial strategies that include diet management, exercise, glucose monitoring, anti-obesity measures, intake of oral antihyperglycaemic agents and, in some cases, insulin administration. Despite the use of multiple oral antihyperglycaemic drugs at maximum dose, some patients are unable to maintain glycaemic control and are recommended to initiate […]

Endocrine Oncology

High-dose Somatostatin Analogues for Progressive Neuroendocrine Tumours

Anna J Sharp, Aimee R Hayes, Ashley Grossman

European Endocrinology. 2020;16(2): Online ahead of journal publication

Neuroendocrine tumours (NETs) represent a heterogeneous group of neoplasms arising from the neuroendocrine cell system, primarily in the gastrointestinal or bronchial tracts. Well-differentiated, low-grade NETs (G1/G2) are often indolent in their behaviour; they may present with a lack of initial symptomatology, and can grow slowly. As a consequence, many cases are diagnosed at advanced stages, […]

Pituitary Disorders

Acromegaly Due to McCune–Albright Syndrome

Martin J Rutkowski, Derek G Southwell, Tyler M Cardinal, Lewis S Blevins

US Endocrinology. 2020;16(1):47–50 DOI: https://doi.org/10.17925/USE.2020.16.1.47

McCune–Albright syndrome (MAS) is a genetic disorder first described by McCune1 and Albright2 in the 1930s as a triad of polyostotic fibrous dysplasia, café-au-lait spots, and precocious puberty (Figure 1). Since then, other hyperfunctioning endocrinopathies have been described in MAS, including hyperthyroidism, Cushing’s syndrome, hypophosphatemic osteomalacia, and acromegaly.3 Patients with MAS display mosaicism as the disease results […]

General Endocrinology

Foreword: US Endocrinology 16.1

Deep Dutta

US Endocrinology. 2020;16(1):9

Welcome to the summer edition of US Endocrinology. In this issue we present authoritative, up-to-date information on a wide range of salient topics. The pandemic of obesity is driving the diabetes epidemic across the globe, with developing countries especially bearing the brunt of this epidemic. We open with an editorial from Malkin-Washeim and Vogliano, where they […]

General Endocrinology

Foreword: European Endocrinology 16.1

John Doupis

European Endocrinology. 2020;16(1):9

Welcome to the latest edition of European Endocrinology. The recent outbreak of COVID-19 has impacted on all aspects of our profession, from the cancellation of medical conferences to the risk that COVID-19 imposes on patients with diabetes. Educating our patients on the importance of optimal glycaemic control has never been more important. This issue features […]

Endocrine Oncology

Pheochromocytoma Due to TMEM127 Mutation – The Importance of Genetic Testing for Clinical Decision

Sílvia Cristina de Sousa Paredes, Sara Gomes de Campos Lopes, Isabel Maria Beleza Ferraz Torres, Marta de Lurdes Fernandes Alves

European Endocrinology. 2020;16(1):72-4

Catecholamine-secreting tumours that arise from chromaffin cells of the adrenal medulla and the sympathetic ganglia are respectively referred to as pheochromocytomas and paragangliomas. The term paraganglioma is also used for tumours derived from parasympathetic tissue in the head and neck, most of which do not produce catecholamines.1 The classic triad of symptoms in patients with […]

Diabetes

Diabetic Polyneuropathy – Advances in Diagnosis and Intervention Strategies

Solomon Tesfaye, Gordon Sloan

European Endocrinology. 2020;16(1):15–20

Diabetic polyneuropathy (DPN) is the most common microvascular complication of diabetes, affecting approximately 50% of all people with diabetes (type 1 diabetes [T1D] and type 2 diabetes [T2D]).1 DPN is a major cause of disability due to sensory loss, gait instability and fall‐related injuries,1–5 and is the strongest risk factor for diabetic foot ulceration and amputation.1–4 Up to […]

Diabetes

Cost Comparison of Flash Continuous Glucose Monitoring with Self-monitoring of Blood Glucose in Adults with Type 1 or Type 2 Diabetes Using Intensive Insulin—From a US Private Payer Perspective

Lizheng Shi, Richard Hellmund

US Endocrinology. 2020;16(1):24–30 DOI: https://doi.org/10.17925/USE.2020.16.1.24

Unmet needs for glucose monitoring in people with diabetes mellitus using intensive insulin Glucose monitoring is essential for people using intensive insulin to inform adjustments to the treatment and management of diabetes. Evidence suggests many people do not adhere to the recommended testing frequency with self-monitoring of blood glucose (SMBG). In the USA, it was […]

FILTER YOUR SEARCH

Speciality:

Journals

Journals Content

Challenges in Women with Diabetes During the COVID-19 Pandemic

Prevalence of Primary Non-adherence with Insulin and Barriers to Insulin Initiation in Patients with Type 2 Diabetes Mellitus – An Exploratory Study in a Tertiary Care Teaching Public Hospital

High-dose Somatostatin Analogues for Progressive Neuroendocrine Tumours

Acromegaly Due to McCune–Albright Syndrome

Foreword: US Endocrinology 16.1

Foreword: European Endocrinology 16.1

Pheochromocytoma Due to TMEM127 Mutation – The Importance of Genetic Testing for Clinical Decision

Diabetic Polyneuropathy – Advances in Diagnosis and Intervention Strategies

Cost Comparison of Flash Continuous Glucose Monitoring with Self-monitoring of Blood Glucose in Adults with Type 1 or Type 2 Diabetes Using Intensive Insulin—From a US Private Payer Perspective

Journal articles and more to your inbox